Regulation of the immune response within the central nervous system

NeuroImmune Biology

Volumn 1, Issue C, 2001, Pages 87-98

  Antel, Jack ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957040497     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(01)80010-7     Document Type: Article

References (58)

1. Antel J.P., and Biernacki K. Migratory Behavior of Th1 and Th2 T Cell across Human Brain Derived Endothelial Cells. Neurology (2000) 54
2. Antel J.P., and Owens T. The attraction of adhesion molecules [editorial]. Ann Neurol 34 (1993) 123-124
3. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
4. Balashov K.E., Rottman J.B., Weiner H.L., and Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96 (1999) 6873-6878
5. Becher B., Prat A., and Antel J.P. The brain-immune connection: immunoregulatory properties of CNS-resident cells. Glia 29 (2000) 293-304
6. Becher B., and Antel J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18 (1996) 1-10
7. Ref Type: In Press. Becher B., Blain M., and Antel J. CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol (2000)
8. Becher B., Fedorowicz V., and Antel J.P. Regulation of CD14 expression on human adult central nervous system-derived microglia. J Neurosci Res 45 (1996) 375-381
9. Boutros T., Croze E., and Yong V.W. Interferon-beta is a potent promoter of nerve growth factor production by astrocytes. J Neurochem 69 (1997) 939-946
10. Brocke S., Piercy C., Steinman L., Weissman I.L., and Veromaa T. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis byblocking secondary leukocyte recruitment. Proc natl Acad Sci USA 96 (1999) 6896-6901
11. Chabot S., Williams G., Hamilton M., Sutherland G., and Yong V.W. Mechanisms of IL-10 production in human microglia-T cell interaction. J Immunol 162 (1999) 6819-6828
12. Constantinescu C.S., Wysocka M., Hilliard B., et al. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 161 (1998) 5097-5104
13. Cross A.H., Girard T.J., Giacoletto K.S., et al. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation [see comments]. J Clin Invest 95 (1995) 2783-2789
14. Cross A.K., and Woodroofe M.N. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28 (1999) 183-189
15. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., and Gregory C.D. Human CD14 mediates recognition and phagocytosis of apoptotic cells [see comments]. Nature 392 (1998) 505-509
16. Dorovini-Zis K., and Huynh H.K. Ultrastructural localization of factor VIII-related antigen in cultured human brain microvessel endothelial cells. J. Histochem. Cytochem 40 (1992) 689-696
17. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., and Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils [see comments]. Nature 382 (1996) 716-719
18. Ford A.L., Foulcher E., Lemckert F.A., and Sedgwick J.D. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184 (1996) 1737-1745
19. Genain C.P., Cannella B., Hauser S.L., and Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis [see comments]. Nat Med 5 (1999) 170-175
20. Girvin A.M., Dal Canto M.C., Rhee L., et al. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J Immunol 164 (2000) 136-143
21. Hassan-Zahraee M., Ladiwala U., Lavoie P.M., et al. Superantigen presenting capacity of human astrocytes. J Neuroimmunol 102 (2000) 131-136
22. Hickey W.F., and Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239 (1988) 290-292
23. Howard L.M., Miga A.J., Vanderlugt C.L., et al. Mechanisms of immunotherapeutic intervention by anti-CD40L. CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 103 (1999) 281-290
24. Huang F., Buttini M., Wyss-Coray T., et al. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing humanamyloid protein precursors. Am J Pathol 155 (1999) 1741-1747
25. Karandikar N.J., Vanderlugt C.L., Eagar T., Tan L., Bluestone J.A., and Miller S.D. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J Immunol 161 (1998) 192-199
26. Karpus W.J., and Kennedy K.J. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 62 (1997) 681-687
27. Katz-Levy Y., Neville K.L., Girvin A.M., et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice [see comments]. J Clin Invest 104 (1999) 599-610
28. Keszthelyi E., Karlik S., Hyduk S., et al. Evidence for a prolonged role of alpha 4 integrin throughout active experimental allergic encephalomyelitis. Neurology 47 (1996) 1053-1059
29. Lee S.J., Zhou T., Choi C., Wang Z., and Benveniste E.N. Differential regulation and function of Fas expression on glial cells. J Immunol 164 (2000) 1277-1285
30. McManus C., Berman J.W., Brett F.M., Staunton H., Farrell M., and Brosnan C.F. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 86 (1998) 20-29
31. McManus C.M., Liu J.S., Hahn M.T., et al. Differential induction of chemokines in human microglia by type I and II interferons. Glia 29 (2000) 273-280
32. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5 (1999) 49-55
33. Neumann H., and Wekerle H. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol 57 (1998) 1-9
34. Nicoletti F., Patti F., Cocuzza C., et al. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J Neuroimmunol 70 (1996) 87-90
35. Noble P.G., Antel J.P., and Yong V.W. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res 633 (1994) 83-90
36. Omari K., and Dorovini-Zis K. Expression of the co-stimulatory molecules B7 and LFA-3 by cerebral endothelium is important for effective T cell priliferation. J Neuroimmunol (1998) 90
37. Pouly S., Becher B., Blain M., and Antel J.P. Interferon modulates human oligodendrocyte susceptibility to fas-mediated apoptosis. J Neuropathology Exp Neurology 59 (2000) 280-286
38. Pouly S., and Antel J.P. Multiple sclerosis and central nervous system demyelination. J Autoimmun 13 (1999) 297-306
39. Prat A., Biernacki B., Becher B., and Antel J.P. B7 expression and antigen presentation by human brain endothelial cells: requirement for pro-inflammatory cytokines. J Neuropathology Exp Neurology 59 (2000) 129-136
40. Prat A., Al Asmi A., Duquette P., and Antel J.P. Lymphocyte migration and multiple sclerosis: relation with disease course and therapy [In Process Citation]. Ann Neurol 46 (1999) 253-256
41. Prat A, Biernacki K, Poirier J, Duquette P and Antel JP. submitted; Migration of Multiplesclerosis lymphocytes through brain endothelium. Brain.
42. Prat A, Biernacki K, Pouly S, Nalbantoglu J, Couture R and Antel JP Kinin B1 Expressionand Function on Human Brain Endothelial Cells. J Neuropathol Exp Neurol-in press
43. Raivich G., Jones L.L., Kloss C.U., Werner A., Neumann H., and Kreutzberg G.W. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites ofneuronal degeneration. J Neurosci 18 (1998) 5804-5816
44. Rezaie P., and Male D. Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech 45 (1999) 359-382
45. Rott O., Tontsch U., and Fleischer B. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens. J Immunol 150 (1993) 87-95
46. Stuve O., Dooley N.P., Uhm J.H., et al. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 40 (1996) 853-863
47. Tong N., Perry S.W., Zhang Q., et al. Neuronal fractalkine expression in HIV-1 ence halitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 164 (2000) 1333-1339
48. Tran E.H., Hoekstra K., van Rooijen N., Dijkstra C.D., and Owens T. Immune invasion of the central nervous system parenchyma and experimental dergic encephalomyelitis, but not leukocyte extravasation from blood, areprevented in acrophage-depleted mice. J Immunol 161 (1998) 3767-3775
49. Traugott U., Scheinberg L.C., and Raine C.S. On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol 8 (1985) 1-14
50. Tubridy N., Behan P.O., Capildeo R., et al. The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group [see comments]. Neurology 63 (1999) 466-472
51. Uhm J., Dooley N.P., Stuve O., Francis G., Duquette P., Antel J.P., and Young V.W. Migratory behavior of lymphocytes isolated from MS patients: effects of interferon 1β therapy. Ann Neurol 46 (1999) 319-324
52. Ulvestad E., Williams K., Matre R., Nyland H., Olivier A., and Antel J. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol 53 (1994) 27-36
53. van der M.K., Hinojoza J.R., and Sobel R.A. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions. J Neuropathol Exp Neurol 58 (1999) 346-358
54. van Noort J.M., van Sechel A.C., van Stipdonk M.J., and Bajramovic J.J. The small heat shock protein alpha B-crystallin as key autoantigen in multiple sclerosis. Prog Brain Res 117 (1998) 435-452
55. Williams K., Dooley N., Ulvestad E., Blain M., Young V.W., and Antel J.P. Antigen presentation by human fetal astrocytes with the cooperative effects of microglia or the microglial-cell derived cytokine II-1. J Neurosci 15 (1995) 1869-1875
56. Williams K., Ulvestad E., and Antel J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol 24 (1994) 3031-3037
57. Windhagen A., Newcombe J., Dangond F., et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 182 (1995) 1985-1996
58. Zujovic V., Benavides J., Vige X., Carter C., and Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29 (2000) 305-315